Guanqun Yi Zhengping Huang Zhixiang Huang Yunqing Wang Weiming Deng Shaoling Zheng Tianwang Li
10.3389/fimmu.2022.914265
Front Immunol
2022 Jul 6;13:914265.
baricitinib case report macrophage activation syndrome maintenance therapy nodular panniculitis
CC BY
https://pubmed.ncbi.nlm.nih.gov/35874753/
Azetidines / therapeutic use Macrophage Activation Syndrome / diagnosis Macrophage Activation Syndrome / drug therapy Macrophage Activation Syndrome / etiology Panniculitis Skin Neoplasms / complications
Azetidines / therapeutic use Macrophage Activation Syndrome / diagnosis Macrophage Activation Syndrome / drug therapy Macrophage Activation Syndrome / etiology Panniculitis Skin Neoplasms / complications Case Reports Research Support, Non-U.S. Gov't Adult Female Humans Methylprednisolone / therapeutic use Purines / therapeutic use Pyrazoles Sulfonamides Young Adult Azetidines Purines Pyrazoles Sulfonamides baricitinib Methylprednisolone
PMC9298961
35874753
Case Report: Baricitinib as an Alternative in the Maintenance Therapy for Macrophage Activation Syndrome Secondary to Nodular Panniculitis
2022